Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

• Glenda E. Gray ,

  * E-mail: Glenda.gray@mrc.ac.za

  Affiliations South African Medical Research Council, Cape Town, South Africa, Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Fatima Laher,

  Affiliation Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Tanya Doherty,

  Affiliations South African Medical Research Council, Cape Town, South Africa, School of Public Health, University of Western Cape, Bellville, South Africa, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Salim Abdool Karim,

  Affiliations Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa, Mailman School of Public Health, Columbia University, New York City, New York, United States of America

  ⨯
• Scott Hammer,

  Affiliation Columbia University Medical Center, New York City, New York, United States of America

  ⨯
• John Mascola,

  Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Bethesda, Maryland, United States of America

  ⨯
• Chris Beyrer,

  Affiliations Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, The International AIDS Society, Geneva, Switzerland

  ⨯
• Larry Corey

  Affiliation HIV Vaccine Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

  ⨯